| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |